Sunshine Biopharma Inc.
SBFM· Nasdaq
SBFMSunshine Biopharma Inc.
Filed May 8, 2012 · 10-Q · 38 days after period end · 0001354488-12-002208
| Metric | Q1 2012 | Q1 2011 | Q1 2010 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Net Income | -$39.34K | -$49.22K | -$1.29M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 8, 2012 · 38 d after period end
